Trinity Biotech Enters Oncology with EpiCapture Acquisition
25 Oct 2024 //
GLOBENEWSWIRE
RS Oncology`s RSO-021 Shows Positive Mesothelioma Phase 1 Data
03 Jun 2024 //
BUSINESSWIRE
RS Oncology Novel Cancer Therapy Oral Presentation At ASCO
01 May 2024 //
BUSINESSWIRE
RS Oncology Announces First Patient Dosed in Phase 2 Study Investigating RSO-021
01 Feb 2024 //
BUSINESSWIRE